$28.34
-0.19-0.67%
At close: Dec 17, 4:00 PM EST
$28.03
-0.31-1.09%
After Hours: 4:42 PM EST
Comments
Loading...
Arcutis Biotherapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ARQT | Benzinga
Arcutis Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 24
EPS Estimate
$0.050
Quarterly Revenue Estimate
$111.37M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$317.93M
Analyze the earnings history of Arcutis Biotherapeutics using advanced sorting and filters.
Arcutis Biotherapeutics (ARQT) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-28 | $0.06 | $-0.10 | 160.0 % |
| Q2 | 2025-08-06 | $-0.13 | $-0.16 | 18.8 % |
| Q1 | 2025-05-06 | $-0.20 | $-0.21 | 4.76 % |
| Q4 | 2025-02-25 | $-0.09 | $-0.27 | 66.7 % |
Arcutis Biotherapeutics (ARQT) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2025-10-28 | $99.22M | $86.74M | 14.4 % |
| Q2 | 2025-08-06 | $81.50M | $73.23M | 11.3 % |
| Q1 | 2025-05-06 | $65.85M | $62.48M | 5.39 % |
| Q4 | 2025-02-25 | $71.36M | $57.75M | 23.6 % |
FAQ
When is Arcutis Biotherapeutics (NASDAQ:ARQT) reporting earnings?
Arcutis Biotherapeutics (ARQT) is scheduled to report earnings on February 24, 2026. The last reported earnings were for reported on October 28, 2025 for Q3.
What were the latest earnings per share (EPS) for Arcutis Biotherapeutics (NASDAQ:ARQT)?
The Actual EPS was $0.06, which beat the estimate of $-0.10.
What were Arcutis Biotherapeutics’s (NASDAQ:ARQT) revenues?
The Actual Revenue was $99.2M, which beat the estimate of $86.7M.
Browse earnings estimates, EPS, and revenue on all stocks.
